1998
DOI: 10.1016/s0304-3940(98)00469-8
|View full text |Cite
|
Sign up to set email alerts
|

Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
31
0

Year Published

2000
2000
2015
2015

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 91 publications
(33 citation statements)
references
References 18 publications
2
31
0
Order By: Relevance
“…Schlicht and colleagues propose to interpret their finding of SOD2 in the PFC of suicide subjects as a compensatory mechanism under the conditions of intensified oxidative stress. This corresponds well with the reports of elevated levels of this enzyme in different psychiatric disorders [34, 4345]. On the other hand, a study by Pae et al [46] failed to support an association of manganese superoxide dismutase (one of the antioxidant enzyme) gene polymorphism (MnSOD: Ala-9Val) with the development of mood disorders or their clinical parameters in the Korean population.…”
Section: Introductionsupporting
confidence: 89%
“…Schlicht and colleagues propose to interpret their finding of SOD2 in the PFC of suicide subjects as a compensatory mechanism under the conditions of intensified oxidative stress. This corresponds well with the reports of elevated levels of this enzyme in different psychiatric disorders [34, 4345]. On the other hand, a study by Pae et al [46] failed to support an association of manganese superoxide dismutase (one of the antioxidant enzyme) gene polymorphism (MnSOD: Ala-9Val) with the development of mood disorders or their clinical parameters in the Korean population.…”
Section: Introductionsupporting
confidence: 89%
“…Several studies find no difference in SOD between AD and controls [15, 29, 31, 36, 66]. Some find significantly lower erythrocyte level [5, 11, 54, 67] and plasma/serum level [11, 26] in AD, while others find significantly higher erythrocyte [6, 7, 21, 22, 6871] and plasma [28] levels in AD. However, only three among these studies have a case number more than 80 [7, 22, 68] and all of them either include only mild-to-moderate AD [22, 68] or have clear severity-classification of AD [7].…”
Section: Resultsmentioning
confidence: 99%
“…Patients with the mentioned neurological diseases showed significantly increased (with respect to controls) plasma levels of TBARS (24, 20, and 19%, respectively), significantly decreased plasma TRAP capacity (32,25, and 28%, respectively) and significantly increased SOD activity in red blood cells (73, 63, and 55%, respectively) with unchanged erythrocyte CAT and GPx activities ( Table 1). The differences in plasma TBARS and TRAP levels and in erythrocyte SOD between the control healthy subjects and the neurological patients with either Alzheimer's disease, vascular dementia or Parkinson disease are highly significant, specially after considering that [35][36][37] and TRAP [38,39]; and for erythrocyte SOD [36][37][38][40][41][42], CAT [36,37,42,43] and GPx activities [36,37,43,44].…”
Section: Resultsmentioning
confidence: 99%